📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. (2018)

First Author: Mosqueira D

Attributed to: MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehy249

PubMed Identifier: 29741611

Publication URI: http://europepmc.org/abstract/MED/29741611

Type: Journal Article/Review

Volume: 39

Parent Publication: European heart journal

Issue: 43

ISSN: 0195-668X